Detalles de la búsqueda
1.
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.
Breast Cancer Res Treat
; 175(1): 5-15, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30671765
2.
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer.
Breast Cancer Res Treat
; 164(3): 649-658, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28508185
3.
Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival.
Breast Cancer Res
; 17: 41, 2015 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25886996
4.
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Breast Cancer Res Treat
; 154(1): 89-97, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26456573
5.
Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference.
Ann Surg Oncol
; 22(10): 3174-83, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26215198
6.
Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review.
JAMA Health Forum
; 5(6): e241388, 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38848090
7.
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen.
Breast Cancer Res Treat
; 137(2): 457-64, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23224144
8.
Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial.
J Urol
; 189(1 Suppl): S51-7; discussion S57-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234632
9.
Correlation of drug-induced apoptosis assay results with oncologist treatment decisions and patient response and survival.
Cancer
; 118(19): 4877-83, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22354845
10.
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
Cancer
; 118(5): 1192-201, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21987386
11.
The anemia impact measure (AIM): development and content validation of a patient-reported outcome measure of anemia symptoms and symptom impacts in cancer patients receiving chemotherapy.
Qual Life Res
; 21(7): 1255-66, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21987032
12.
Prospective Comparison of Medical Oncologists and a Machine Learning Model to Predict 3-Month Mortality in Patients With Metastatic Solid Tumors.
JAMA Netw Open
; 5(5): e2214514, 2022 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35639380
13.
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804935
14.
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
J Clin Med
; 11(22)2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36431215
15.
Integrating Academic and Community Cancer Care and Research through Multidisciplinary Oncology Pathways for Value-Based Care: A Review and the City of Hope Experience.
J Clin Med
; 10(2)2021 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33430334
16.
Strategies to Improve Participation of Older Adults in Cancer Research.
J Clin Med
; 9(5)2020 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455877
17.
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07).
Nat Commun
; 11(1): 5824, 2020 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203854
18.
A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology.
JCO Oncol Pract
; 16(4): 191-199, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223701
19.
Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial.
J Urol
; 182(2): 509-15; discussion 515-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19524963
20.
A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach.
Clin Breast Cancer
; 9(1): 16-22, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19299235